InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Pierce Valerie L. Director active across 1 company, notably NGM Biopharmaceuticals INC. In total, 3 disclosures have been logged. Activity tracked since 2 March 2023. The latest transaction was disclosed on 16 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations